Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells in Multiple Sclerosis
NCT01377870Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Dec 2011
- Primary completion
- Mar 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in multiple sclerosis (MS), sponsored by Royan Institute. Started Dec 2011; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01377870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377870.